An experimental therapy designed to change a single letter of short-lived mRNA molecules has corrected a genetic mutation ...

Plus, news about TenNor Therapeutics, Gan & Lee Pharmaceuticals, Orasis and Optus Pharmaceuticals: Exscientia receives $15M milestone from Sanofi: The companies are advancing two programs as ...

Investors have been placing bets into startups that help members of low-income households on Medicaid insurance get care. A ...

Novavax’s post-Covid path ran into a speed bump Wednesday, as the company announced a clinical hold on its Covid-influenza ...

Starboard Value may have lost its first skirmish with Pfizer. But the activist investor has a track record of protracted, ...

Almost a year ago, Sanofi made history for the wrong reasons. Last October, CEO Paul Hudson announced strategic changes ...

Takeda will not move forward with Wave Life Sciences on a Huntington’s disease drug, ending their collaboration that first ...

Neurogastrx believes its drug could treat one of the most troublesome side effects of one of the industry's biggest blockbusters. On Wednesday, the Boston-area biotech said that its experimental drug ...

Stem cell biologist William Rust has been quietly working on a cure for diabetes for more than a decade. Later this year, ...

GSK on Tuesday unveiled a lawsuit filed against Moderna in Delaware federal court, alleging that its patented inventions ...

Jazz Pharmaceuticals announced Tuesday that adding its small cell lung cancer drug Zepzelca to a maintenance treatment ...

Johnson & Johnson beat investors’ expectations despite its medtech unit underperforming, with execs pointing to the Asia-Pacific region as a continued source of struggle. Executives said on the ...